Yuichi Miyashima Yuichi Honma Koichiro Miyagawa Shinji Oe Michio Senju Michihiko Shibata Masaaki Hiura Shintaro Abe Masaru Harada
10.2169/internalmedicine.55.7347
Intern Med
2016;55(24):3595-3601.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/27980259/
Antiviral Agents / adverse effects Chemical and Drug Induced Liver Injury / drug therapy Cholecystitis / chemically induced Hepatitis C, Chronic / drug therapy Imidazoles / adverse effects Isoquinolines / adverse effects Sulfonamides / adverse effects
Antiviral Agents / adverse effects Chemical and Drug Induced Liver Injury / drug therapy Cholecystitis / chemically induced Hepatitis C, Chronic / drug therapy Imidazoles / adverse effects Isoquinolines / adverse effects Sulfonamides / adverse effects Case Reports Aged Antiviral Agents / therapeutic use Asian People Carbamates Chemical and Drug Induced Liver Injury / blood Cholecystitis / complications Combined Modality Therapy Drug Therapy, Combination Female Genotype Hepatitis C, Chronic / complications Humans Imidazoles / administration & dosage Imidazoles / therapeutic use Isoquinolines / administration & dosage Isoquinolines / therapeutic use Pyrrolidines Sulfonamides / administration & dosage Sulfonamides / therapeutic use Treatment Outcome Valine / analogs & derivatives Antiviral Agents Carbamates Imidazoles Isoquinolines Pyrrolidines Sulfonamides Valine daclatasvir asunaprevir
PMC5283959
27980259
Daclatasvir and Asunaprevir Combination Therapy-induced Hepatitis and Cholecystitis with Coagulation Disorder due to Hypersensitivity Reactions
2016